Effects of a Periodic Repetitive Transcranial Magenetic Stimulation in Parkinson Disease

Parkinson's Disease Clinical Trial

Official title: Effects of a Periodic Repetitive Transcranial Magenetic Stimulation in Parkinson Disease

Status Active, not recruiting

Clinical Trial Summary

Previous studies have shown that repetitive transcranial magnetic stimulation(rTMS) can improve clinical symptoms of Parkinson's disease(PD). Continuous theta-burst stimulation(cTBS) is a novel rTMS protocol that produces physiological effects b acting on neurons in the brain, which can decrease the excitability of motor system. This study aims to explore the long-term effects of cTBS on improvement of movement symptoms in patients with PD.

Clinical Trial Description

This was a open-label clinical trial to assess the Effects of a Periodic Repetitive Transcranial Magenetic Stimulation in Parkinson Disease. Participants were randomly assigned to the cTBS group and the control group on a 1:1 basis using age as a stratification factor. In the cTBS group, after baseline assessment, participants received cTBS treatment on the left supplementary motor area(SMA) for 14 days, and symptoms were assessed on the second day after treatment. Ten weeks after completion of assessment, a second cTBS session was performed, with all patients taking stable doses of antiparkinsonian medications. The control group only received drug intervention, and symptom assessment was conducted at weeks 13, 23 , 33 , and 43. To rule out the influence of medication on symptom assessment, all patients stopped taking medication for at least 12 hours before assessment. ;

Related Conditions & MeSH terms

• Parkinson Disease
• Parkinson's Disease
• Transcranial Magnetic Stimulation

• NCT number: NCT06365190
• Study type: Interventional
• Source: Anhui Medical University
• Status: Active, not recruiting
• Phase: N/A
• Start date: April 6, 2020
• Completion date: July 31, 2024